The Comparison of the Selected Parameters of Brain Injury and Interleukins in the CSF in Patients Diagnosed De Novo with RRMS Compared to the Control Group.
Bożena AdamczykNatalia MorawiecGabriela MamakSylwia BoczekDominika BrzękNatalia TrędotaPatryk WalochaZenon Paweł CzubaMichał BłachutWojciech BartmanMonika Adamczyk-SowaPublished in: Diagnostics (Basel, Switzerland) (2023)
The role of the above molecules in MS is promising. However, further research is warranted to define their precise functions.